CART123
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CART123, covering 2026-01-16 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]